Top 3 search results for "are race and ethnicity risk factors for breast cancer" in Treatments. To see all results and access other features, sign up for free.

Phesgo (Pertuzumab, trastuzumab, and hyaluronidase-zzxf)

Overview
Phesgo is a combination prescription drug approved by the U.S. Food and Drug Administration (FDA) for use with chemotherapy to treat adults with early-stage HER-2 positive breast cancer. Phesgo is also approved… read more

Neulasta (Pegfilgrastim)

Overview

Neulasta is a prescription drug approved by the Food and Drug Administration (FDA) to lower the risk of developing infections after receiving chemotherapy or some types of radiation. Neulasta is also known by… read more

Neupogen (Filgrastim)

Overview
Neupogen is a prescription drug approved by the Food and Drug Administration (FDA) to help prevent febrile neutropenia (a lack of white blood cells, plus fever). If your white blood cell count is low due to… read more